Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii

Paula Espinal1, Noraida Mosqueda1, Murat Telli2

  • 1ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

Insights

This study identifies a novel Acinetobacter species carrying the blaNDM-1 gene on a transferable plasmid. This finding highlights the potential spread of carbapenem resistance among Acinetobacter before it reaches common clinical strains.

Area of Science:

  • Molecular microbiology and infectious diseases.
  • Antimicrobial resistance and bacterial genomics.

Background:

  • The emergence of carbapenem resistance in Acinetobacter species poses a significant global health threat.
  • The blaNDM-1 gene is a major determinant of carbapenem resistance, frequently found on mobile genetic elements.

Purpose of the Study:

  • To molecularly characterize a blaNDM-1-positive Acinetobacter clinical isolate from Turkey.
  • To investigate the genetic context and potential dissemination of the blaNDM-1 gene within Acinetobacter populations.

Main Methods:

  • Amplified 16S ribosomal DNA restriction analysis (ARDRA) for species identification.
  • Molecular sequencing techniques to confirm species and characterize the blaNDM-1 gene.
  • Plasmid analysis to determine its location and conjugative potential.

Main Results:

  • Identification of a distinct Acinetobacter clinical isolate from Turkey, potentially representing a novel species based on ARDRA and sequencing.
  • The blaNDM-1 gene was located on a conjugative plasmid within this isolate.
  • This plasmid was found to be prevalent among non-baumannii Acinetobacter isolates in the study population.

Conclusions:

  • A novel Acinetobacter species harboring blaNDM-1 has been identified, indicating a new reservoir for carbapenem resistance.
  • The presence of blaNDM-1 on a conjugative plasmid suggests a high risk of horizontal gene transfer.
  • This resistance determinant may spread among Acinetobacter species, including clinically significant ones like A. baumannii, posing future therapeutic challenges.